EMvision Medical Devices (EMV.AX) Stock Price

EMvision Medical Devices Price

ASX·CLOSED
1.50
​
Market closed

Over the last 7 years EMvision Medical Devices grew revenue by 39.4% annually, reaching 5.05 M AUD. For EMvision Medical Devices, the net margin of -194.1% is up versus -494.4% a few years ago. The consensus 12-month price target for EMvision Medical Devices is 3.21 AUD, about 114.2% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

EMvision Medical Devices stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EMvision Medical Devices business model & stock analysis

EMvision Medical Devices Ltd develops and commercializes medical imaging technology, focusing on portable diagnostic devices for stroke and other medical emergencies. The company's lead product is a portable, non-ionizing brain scanner that provides non-invasive imaging of biological tissue for clinical insights. Its second-generation device is designed for integration into standard ambulances, enabling pre-hospital stroke diagnosis and care in various locations. The firm targets healthcare providers and emergency medical services seeking advanced diagnostic tools for rapid patient assessment. The company's revenue streams come from the sale of its medical imaging devices, including the portable brain scanner and ambulance-integrated systems. These products are marketed to hospitals, clinics, and emergency response organizations that require efficient diagnostic solutions for stroke and other acute conditions. The firm's technology addresses the growing need for accessible, real-time imaging in both clinical and pre-hospital settings. EMvision Technology serves as the foundation for the company's product development, focusing on non-invasive neuroimaging solutions. The portable nature of the devices allows for use in diverse environments, from emergency rooms to ambulances, supporting the company's mission to improve diagnostic speed and accessibility. The product pipeline emphasizes innovation in medical imaging for critical care scenarios.

Frequently asked questions about EMvision Medical Devices

Analysts currently set an average price target of 3.21 AUD for the EMvision Medical Devices stock (median: 3.21 AUD), implying +115.6 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the EMvision Medical Devices stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the EMvision Medical Devices share trades at 0.94 EUR (1.50 AUD).

The EMvision Medical Devices share (EMV.AX) is listed on 1 stock exchanges, including: ASX (EMV.AX).

The revenue cannot currently be calculated for EMvision Medical Devices.

The profit of EMvision Medical Devices is -8.32 M AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of EMvision Medical Devices is currently -16.77. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the EMvision Medical Devices stock.

The P/S cannot be calculated for EMvision Medical Devices currently.

The Eulerpool Quality Score for EMvision Medical Devices is 2/10.

The ISIN of EMvision Medical Devices is AU0000028375. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of EMvision Medical Devices is EMV.AX. The ticker symbol is used to trade EMvision Medical Devices shares on the stock exchange.

Fair ValueTerminal
1.31 AUD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Australia
Currency
AUD
Initial public offering
Dec 13, 2018
ISIN
AU0000028375
Cusip
Q34825101
Market capitalization
139.41 M AUDMicro Cap
52-Week Range
PEG
-1.72
P/E ratio
P/Ee 2027
-11.20
P/Ee 2028
-10.35
P/Ee 2029
-8.48
P/Se
27.89
EV/EBIT
—
P/B Ratio
8.84
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-43.37 %
Last updated Oct 30, 2026, 3:12 AM

EMvision Medical Devices Peer Group

EMvision Medical Devices Ticker

ASX · EMV.AX

EMvision Medical Devices FIGI

EMV:AU · BBG00MRCYX78EMV:AT · BBG00MRCYX87EMV:AH · BBG00MRCYXD1